Literature DB >> 2117766

Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay.

N Nakamura1, Y Kusunoki, M Akiyama.   

Abstract

The recent development of an in vitro lymphocyte colony assay makes it possible to examine variations in the radiosensitivity of humans using peripheral blood lymphocytes (PBL) instead of the skin fibroblast assay. Our recent study (M. Hakoda et al., Mutat. Res. 197, 161-169, 1988) showed that most of the colonies consisted of lymphocytes bearing CD4 or CD8 antigens. Since the fraction of CD4+ and CD8+ cells in PBL differs among individuals, we suspected that individual radiosensitivity might be biased by the different subset frequencies if the dose-survival curves of the CD4+ and CD8+ cells were different from each other. In the present study, CD4+ (helper/inducer T) and CD8+ (suppressor/cytotoxic T) lymphocytes were isolated from PBL and their dose-survival curves were determined. The results showed that the D10 (dose required to reduce the surviving fraction to 10%) was similar for these two types of cells [3.13 +/- 0.10 Gy (mean +/- SD) for CD4+, 3.34 +/- 0.50 Gy for CD8+ and 3.14 +/- 0.17 Gy for the unsorted cells], supporting the use of the whole PBL population for the screening of individuals with altered radiosensitivity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117766

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  66 in total

1.  Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma.

Authors:  Hwa Kyung Byun; Nalee Kim; Sangjoon Park; Jinsil Seong
Journal:  Strahlenther Onkol       Date:  2019-04-15       Impact factor: 3.621

2.  CD4+ memory T cells retain surface expression of CD31 independently of thymic function in patients with lymphoproliferative disorders following autologous hematopoietic stem-cell transplantation.

Authors:  Egor V Batorov; Marina A Tikhonova; Irina V Kryuchkova; Vera V Sergeevicheva; Svetlana A Sizikova; Galina Y Ushakova; Dariya S Batorova; Andrey V Gilevich; Alexander A Ostanin; Ekaterina Y Shevela; Elena R Chernykh
Journal:  Int J Hematol       Date:  2017-03-14       Impact factor: 2.490

3.  Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal Canal.

Authors:  Grace Lee; Daniel W Kim; Vinayak Muralidhar; Devarati Mitra; Nora K Horick; Christine E Eyler; Theodore S Hong; Lorraine C Drapek; Jill N Allen; Lawrence S Blaszkowsky; Bruce Giantonio; Aparna R Parikh; David P Ryan; Jeffrey W Clark; Jennifer Y Wo
Journal:  Oncologist       Date:  2020-09-12

4.  Lymphopenia during radiotherapy in patients with oropharyngeal cancer.

Authors:  Sweet Ping Ng; Houda Bahig; Amit Jethanandani; Courtney Pollard; Joel Berends; Erich M Sturgis; Faye M Johnson; Baher Elgohari; Hesham Elhalawani; David I Rosenthal; Heath D Skinner; G Brandon Gunn; Jack Phan; Steven J Frank; Abdallah S R Mohamed; Clifton D Fuller; Adam S Garden
Journal:  Radiother Oncol       Date:  2020-01-10       Impact factor: 6.280

5.  Systemic Inflammation After Radiation Predicts Locoregional Recurrence, Progression, and Mortality in Stage II-III Triple-Negative Breast Cancer.

Authors:  Alexander D Sherry; Rie von Eyben; Neil B Newman; Paulina Gutkin; Ingrid Mayer; Kathleen Horst; A Bapsi Chakravarthy; Marjan Rafat
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-12-03       Impact factor: 7.038

Review 6.  Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities.

Authors:  Ravi B Patel; Claire C Baniel; Raghava N Sriramaneni; Kristin Bradley; Stephanie Markovina; Zachary S Morris
Journal:  Brachytherapy       Date:  2018-08-02       Impact factor: 2.362

7.  Patterns of Radiation-Associated Lymphopenia in Children with Cancer.

Authors:  Miloš D Miljković; Stuart A Grossman; Xiaobu Ye; Susannah Ellsworth; Stephanie Terezakis
Journal:  Cancer Invest       Date:  2016-01-08       Impact factor: 2.176

8.  Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day 7 interim analysis of a registered clinical trial.

Authors:  Clayton B Hess; Zachary S Buchwald; William Stokes; Tahseen H Nasti; Jeffrey M Switchenko; Brent D Weinberg; James P Steinberg; Karen D Godette; David Murphy; Rafi Ahmed; Walter J Curran; Mohammad K Khan
Journal:  Cancer       Date:  2020-09-28       Impact factor: 6.860

9.  90Y Resin Microspheres Radioembolization for Colon Cancer Liver Metastases Using Full-Strength Contrast Material.

Authors:  I Kurilova; R G H Beets-Tan; G A Ulaner; F E Boas; E N Petre; H Yarmohammadi; E Ziv; A R Deipolyi; L A Brody; M Gonen; Constantinos T Sofocleous
Journal:  Cardiovasc Intervent Radiol       Date:  2018-05-15       Impact factor: 2.740

10.  A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy.

Authors:  Wonmo Sung; Clemens Grassberger; Aimee Louise McNamara; Lucas Basler; Stefanie Ehrbar; Stephanie Tanadini-Lang; Theodore S Hong; Harald Paganetti
Journal:  Radiother Oncol       Date:  2020-07-15       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.